Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
BioMarinbiomarin.comBioMarin is a global biotechnology company with eight marketed products that treat life-threatening conditions. Since 1997, BioMarin has applied scientific expertise to understand genetic conditions to create transformative medicines across multiple modalities, with approved treatments for achondroplasia, severe hemophilia A, and other rare inherited and lysosomal storage diseases. The company maintains an industry-leading pipeline of investigational medicines at various stages of clinical and preclinical development, driven by breakthrough science and patient-focused collaboration.
Parse Score
